Salbutamol, Pharmacogenetics and Breathing Mechanics

PHASE4CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

August 31, 2016

Conditions
BronchoconstrictionInhaled SalbutamolCycling Performance
Interventions
DRUG

Salbutamol

60 minutes prior to the start of a 10km cycling time trial on a bike ergometer, subjects will inhale either 400ug of salbutamol 1600ug of salbutamol or 400ug of placebo in a randomly assigned manner in a single dose.

DRUG

Placebo

Trial Locations (1)

V6T 1Z1

Environmental Physiology Laboratory, University of British Columbia, Vancouver

All Listed Sponsors
collaborator

World Anti-Doping Agency

OTHER

lead

University of British Columbia

OTHER

NCT01903785 - Salbutamol, Pharmacogenetics and Breathing Mechanics | Biotech Hunter | Biotech Hunter